Literature DB >> 31214938

Imaging of cardiac amyloidosis: Will this become a unique application for dual-isotope imaging?

Sarah Cuddy1,2,3, Sharmila Dorbala1,2,3, Marcelo F Di Carli4,5,6,7.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31214938      PMCID: PMC6918001          DOI: 10.1007/s12350-019-01754-4

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  14 in total

1.  Cardiac amyloidosis: a treatable disease, often overlooked.

Authors:  Rodney H Falk
Journal:  Circulation       Date:  2011-08-30       Impact factor: 29.690

2.  Imaging cardiac amyloidosis: a pilot study using ¹⁸F-florbetapir positron emission tomography.

Authors:  Sharmila Dorbala; Divya Vangala; James Semer; Christopher Strader; John R Bruyere; Marcelo F Di Carli; Stephen C Moore; Rodney H Falk
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-20       Impact factor: 9.236

3.  Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis.

Authors:  Scott D Solomon; David Adams; Arnt Kristen; Martha Grogan; Alejandra González-Duarte; Mathew S Maurer; Giampaolo Merlini; Thibaud Damy; Michel S Slama; Thomas H Brannagan; Angela Dispenzieri; John L Berk; Amil M Shah; Pushkal Garg; Akshay Vaishnaw; Verena Karsten; Jihong Chen; Jared Gollob; John Vest; Ole Suhr
Journal:  Circulation       Date:  2019-01-22       Impact factor: 29.690

4.  Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.

Authors:  Adam Castano; Muhammad Haq; David L Narotsky; Jeff Goldsmith; Richard L Weinberg; Rachelle Morgenstern; Ted Pozniakoff; Frederick L Ruberg; Edward J Miller; John L Berk; Angela Dispenzieri; Martha Grogan; Geoffrey Johnson; Sabahat Bokhari; Mathew S Maurer
Journal:  JAMA Cardiol       Date:  2016-11-01       Impact factor: 14.676

5.  Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.

Authors:  Enrica Perugini; Pier Luigi Guidalotti; Fabrizio Salvi; Robin M T Cooke; Cinzia Pettinato; Letizia Riva; Ornella Leone; Mohsen Farsad; Paolo Ciliberti; Letizia Bacchi-Reggiani; Francesco Fallani; Angelo Branzi; Claudio Rapezzi
Journal:  J Am Coll Cardiol       Date:  2005-09-20       Impact factor: 24.094

6.  11C-Pittsburgh B PET imaging in cardiac amyloidosis.

Authors:  Seung-Pyo Lee; Eun Seong Lee; Hongyoon Choi; Hyung-Jun Im; Youngil Koh; Min-Ho Lee; Ji-Hyun Kwon; Jin Chul Paeng; Hyung-Kwan Kim; Gi Jeong Cheon; Yong-Jin Kim; Inho Kim; Sung-Soo Yoon; Jeong-Wook Seo; Dae-Won Sohn
Journal:  JACC Cardiovasc Imaging       Date:  2014-11-04

7.  (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.

Authors:  Sabahat Bokhari; Adam Castaño; Ted Pozniakoff; Susan Deslisle; Farhana Latif; Mathew S Maurer
Journal:  Circ Cardiovasc Imaging       Date:  2013-02-11       Impact factor: 7.792

8.  Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.

Authors:  Mathew S Maurer; Jeffrey H Schwartz; Balarama Gundapaneni; Perry M Elliott; Giampaolo Merlini; Marcia Waddington-Cruz; Arnt V Kristen; Martha Grogan; Ronald Witteles; Thibaud Damy; Brian M Drachman; Sanjiv J Shah; Mazen Hanna; Daniel P Judge; Alexandra I Barsdorf; Peter Huber; Terrell A Patterson; Steven Riley; Jennifer Schumacher; Michelle Stewart; Marla B Sultan; Claudio Rapezzi
Journal:  N Engl J Med       Date:  2018-08-27       Impact factor: 91.245

9.  Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

Authors:  Julian D Gillmore; Mathew S Maurer; Rodney H Falk; Giampaolo Merlini; Thibaud Damy; Angela Dispenzieri; Ashutosh D Wechalekar; John L Berk; Candida C Quarta; Martha Grogan; Helen J Lachmann; Sabahat Bokhari; Adam Castano; Sharmila Dorbala; Geoff B Johnson; Andor W J M Glaudemans; Tamer Rezk; Marianna Fontana; Giovanni Palladini; Paolo Milani; Pierluigi L Guidalotti; Katarina Flatman; Thirusha Lane; Frederick W Vonberg; Carol J Whelan; James C Moon; Frederick L Ruberg; Edward J Miller; David F Hutt; Bouke P Hazenberg; Claudio Rapezzi; Philip N Hawkins
Journal:  Circulation       Date:  2016-04-22       Impact factor: 29.690

10.  Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis.

Authors:  Alicia M Maceira; Sanjay K Prasad; Philip N Hawkins; Michael Roughton; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2008-11-25       Impact factor: 5.364

View more
  2 in total

1.  Older patients with cardiovascular disease: A new frontier for nuclear cardiology?

Authors:  Rob S B Beanlands
Journal:  J Nucl Cardiol       Date:  2019-10       Impact factor: 5.952

2.  Diagnostic performance of CMR, SPECT, and PET imaging for the detection of cardiac amyloidosis: a meta-analysis.

Authors:  Zhaoye Wu; Chunjing Yu
Journal:  BMC Cardiovasc Disord       Date:  2021-10-07       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.